Gabapentin 100mg Blister
Gabapentin Capsule
Product Images NDC 67877-224
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 67877-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Gabapentin-100mg-cap (Gabapentin 100mg Cap)
Gabapentin 300mg Blister
Gabapentin-300mg-cap (Gabapentin 300mg Cap)
Gabapentin 400mg Blister
Gabapentin-400mg-cap (Gabapentin 400mg Cap)
Gabapentin-equation (Gabapentin Equation)
Gabapentin Fig1
The text describes a study with a 4-week dose titration period followed by a 4-week fixed dose period, where the pain score was measured. The study compares the effects of a placebo and Gabapentin at a dosage of 3600 mg/day. The text also includes a visual diagram, but it is not clear what it represents.*
Gabapentin Fig2
This appears to be a table displaying information related to a study on pain management with different doses of gabapentin and a placebo. The table shows mean pain scores at baseline and over the course of several weeks during the study. There are also columns for different dosage levels of gabapentin.*
Gabapentin Fig3
Gabapentin-fig4 (Gabapentin Fig4)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
